Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Pharma
  4. Pharma — September 2024

Pharma — September 2024

Planlagt Fastgjort Låst Flyttet Pharma
21 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #11

    ALK ser stort potentiale i markedet for peanutallergi https://proinvestor.com/investornyt/1215776/alk-ser-stort-potentiale-i-markedet-for-peanutallergi

    1 Reply Last reply
    0
    • L Offline
      L Offline
      LP90
      wrote on sidst redigeret af
      #12

      Godmorgen 🙂

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #13

        ALK: Fortsat optismisme om at få husstøvmidevaccine til Kina trods udfordringer https://proinvestor.com/investornyt/1216268/alk-fortsat-optismisme-om-at-fa-husstovmidevaccine-til-kina-trods-udfordringer

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #14

          J&J's Subsidiary Red River Talc Files For Chapter 11 Bankruptcy To Resolve Ovarian Cancer Claims https://proinvestor.com/investornyt/1216779/jampjs-subsidiary-red-river-talc-files-for-chapter-11-bankruptcy-to-resolve-ovarian-cancer-claims

          1 Reply Last reply
          0
          • P Offline
            P Offline
            ProinvestorNEWS
            wrote on sidst redigeret af
            #15

            Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights https://proinvestor.com/investornyt/1216766/astrazeneca-azn-suffers-a-larger-drop-than-the-general-market-key-insights

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #16

              Is Johnson & Johnson Stock a Buy?https://proinvestor.com/investornyt/1216914/is-johnson-amp-johnson-stock-a-buy

              1 Reply Last reply
              0
              • P Offline
                P Offline
                ProinvestorNEWS
                wrote on sidst redigeret af
                #17

                FDA greenlights Sanofi's Sarclisa in frontline multiple myeloma https://firstwordpharma.com/story/5897967

                1 Reply Last reply
                0
                • P Offline
                  P Offline
                  ProinvestorNEWS
                  wrote on sidst redigeret af
                  #18

                  Sanofi gears up to seek approval of BTK inhibitor tolebrutinib in MS https://firstwordpharma.com/story/5897608

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #19

                    Sanofi rykker tættere på at udskille forbrugerdivision: Banker er klar med milliarder https://proinvestor.com/investornyt/1217838/sanofi-rykker-taettere-pa-at-udskille-forbrugerdivision-banker-er-klar-med-milliarder

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #20

                      Lilly's Alzheimer's therapy Kisunla gains approval in Japan https://firstwordpharma.com/story/5898393

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #21

                        Lundbeck-topchef ser ikke patentudløb sende selskabet helt af sporet https://proinvestor.com/investornyt/1218939/lundbeck-topchef-ser-ikke-patentudlob-sende-selskabet-helt-af-sporet

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          ProinvestorNEWS
                          wrote on sidst redigeret af
                          #22

                          Lundbeck vil forstå kronisk nervesygdom bedre med nyt studie https://proinvestor.com/investornyt/1219563/lundbeck-vil-forsta-kronisk-nervesygdom-bedre-med-nyt-studie

                          1 Reply Last reply
                          0

                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                          With your input, this post could be even better 💗

                          Tilmeld Log ind
                          Svar
                          • Svar som emne
                          Login for at svare
                          • Ældste til nyeste
                          • Nyeste til ældste
                          • Most Votes


                          • Log ind

                          • Har du ikke en konto? Tilmeld

                          • Login or register to search.
                          Powered by NodeBB Contributors
                          • First post
                            Last post
                          0
                          • Kategorier
                          • Seneste
                          • Etiketter
                          • Populære
                          • Verden
                          • Bruger
                          • Grupper